Tsumura & Co. (TSMRF)
OTHER OTC:TSMRF
Holding TSMRF?
Track your performance easily

Tsumura & Co (TSMRF) Stock Price & Analysis

5 Followers

TSMRF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%5.29%4.92%89.79%
0.00%
Insiders
4.92% Other Institutional Investors
89.79% Public Companies and
Individual Investors

TSMRF FAQ

What was Tsumura & Co.’s price range in the past 12 months?
Tsumura & Co. lowest stock price was $16.85 and its highest was $29.70 in the past 12 months.
    What is Tsumura & Co.’s market cap?
    Currently, no data Available
    When is Tsumura & Co.’s upcoming earnings report date?
    Tsumura & Co.’s upcoming earnings report date is Nov 06, 2024 which is 8 days ago.
      How were Tsumura & Co.’s earnings last quarter?
      Tsumura & Co. released its earnings results on Aug 05, 2024. The company reported $1.048 earnings per share for the quarter, beating the consensus estimate of $0.666 by $0.382.
        Is Tsumura & Co. overvalued?
        According to Wall Street analysts Tsumura & Co.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Tsumura & Co. pay dividends?
          Tsumura & Co. pays a Annually dividend of $0.48 which represents an annual dividend yield of 2.06%. See more information on Tsumura & Co. dividends here
            What is Tsumura & Co.’s EPS estimate?
            Tsumura & Co.’s EPS estimate is $0.67.
              How many shares outstanding does Tsumura & Co. have?
              Tsumura & Co. has 76,758,360 shares outstanding.
                What happened to Tsumura & Co.’s price movement after its last earnings report?
                Tsumura & Co. reported an EPS of $1.048 in its last earnings report, beating expectations of $0.666. Following the earnings report the stock price went down -5.622%.
                  Which hedge fund is a major shareholder of Tsumura & Co.?
                  Currently, no hedge funds are holding shares in TSMRF
                  ---

                  Tsumura & Co Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  50.53%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  8.86%
                  Trailing 12-Months
                  Asset Growth
                  -1.34%
                  Trailing 12-Months

                  Company Description

                  Tsumura & Co.

                  Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Takeda Pharmaceutical Company
                  Sanofi
                  GlaxoSmithKline
                  Baxter International
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis